Oxford, UK-based Genomics plc has completed a $30m funding round, which the company will use to expand its work on its patient-centric, population health platform.
Foresite Capital surpassed its $650 million goal to close its largest fund yet, with $668 million in capital commitments. While the firm doesn't limit itself by therapeutic area...